NASDAQ: VVOS - Vivos Therapeutics, Inc.

Yield per half year: +95.38%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Vivos Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children.

more details
It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2020-12-11
ISIN US92859E1082
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://vivos.com
Цена ао 4.47
Change price per day: -2.31% (4.76)
Change price per week: -6.63% (4.98)
Change price per month: +36.76% (3.4)
Change price per 3 month: +72.22% (2.7)
Change price per half year: +95.38% (2.38)
Change price per year: -62.62% (12.44)
Change price per 3 year: +76.14% (2.64)
Change price per 5 year: 0% (4.65)
Change price per 10 year: 0% (4.65)
Change price per year to date: +71.59% (2.71)
All parameters

Underestimation

Title Value Grade
P/S 0.9949 9
P/BV 33.41 1
P/E 0 0
EV/EBITDA -0.8445 0
Total: 5

Efficiency

Title Value Grade
ROA, % -126.59 0
ROE, % -3304.87 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1196 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 21.06 4
Yield Ebitda, % 70.15 8
Yield EPS, % 1706.85 10
Total: 7.2
More

Institutions Volume Share, %
Strategic Wealth Investment Group, LLC 128789 9.67
Vanguard Group Inc 24601 1.85
Geode Capital Management, LLC 8078 0.61
Blue Trust, Inc. 4000 0.3
Credit Agricole S.A. 2364 0.18
State Street Corporation 1826 0.14
LPL Financial LLC 1419 0.11
Northern Trust Corporation 1186 0.09
HighTower Advisors, LLC 746 0.06
SignatureFD, LLC 547 0.04



Head Job title Payment Year of birth
Mr. R. Kirk Huntsman Co-Founder, Chairman of the Board & CEO 482.16k 1958 (67 years)
Mr. Bradford K. Amman CFO, Treasurer & Secretary 335.53k 1962 (63 years)
Mr. Todd Huntsman Co-Founder & Senior VP of Product and Technology N/A
Ms. RaeAnn Byrnes Co-Founder and Senior VP of Events & Clinical Advisory Services N/A
Ms. Susan McCullough Co-Founder & Executive VP of Operations N/A
Mr. Nicholas M. DeGennaro Senior Vice President of Medical Integration Division N/A
Ms. Ruth Hembree Senior Vice President of Practice Services N/A
Ms. Stephanie Huebner Senior Vice President of Dental Service Integration N/A
Mr. John Ballard Senior Vice President of Technology N/A

Address: United States, Littleton. CO, 7921 Southpark Plaza - open in Google maps, open in Yandex maps
Website: https://vivos.com